Dr Tom Ewen Stuart Horswell Dr Helen Bosomworth Joe Lowenstein Grant Richardson et al. | Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma | 2024 |
|